We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGN
3126
DELISTED
Aegion Corp
AEGN
| $894K | ﹤0.01% |
40,030
-15,117
| -27% | -$327K |
|
3127
CTS Corp
CTS
$1.83B
| $893K | ﹤0.01% |
29,763
-1,993
| -6% | -$57.7K |
|
3128
Opko Health
OPK
$985M
| $893K | ﹤0.01% |
607,686
+92,905
| +18% | +$156K |
|
3129
ePlus
PLUS
$2.42B
| $892K | ﹤0.01% |
21,148
-1,598
| -7% | -$65.1K |
|
3130
e.l.f. Beauty
ELF
$4.89B
| $890K | ﹤0.01% |
55,171
+40,115
| +266% | +$668K |
|
3131
Inspire Medical Systems
INSP
$1.45B
| $890K | ﹤0.01% |
11,993
-7,110
| -37% | -$457K |
|
3132
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
| $890K | ﹤0.01% |
+7,090
| New | +$860K |
|
|
ATRI
3133
DELISTED
Atrion Corp
ATRI
| $888K | ﹤0.01% |
1,182
-342
| -22% | -$258K |
|
3134
Dillards
DDS
$9.19B
| $886K | ﹤0.01% |
12,064
-15,027
| -55% | -$1.07M |
|
3135
Construction Partners
ROAD
$5.84B
| $886K | ﹤0.01% |
52,535
+37,164
| +242% | +$652K |
|
3136
V2X
VVX
$2.83B
| $885K | ﹤0.01% |
+17,259
| New | +$832K |
|
|
RDUS
3137
DELISTED
Radius Recycling
RDUS
| $880K | ﹤0.01% |
40,572
+2,818
| +7% | +$60K |
|
3138
AtriCure
ATRC
$1.92B
| $879K | ﹤0.01% |
27,015
-3,945
| -13% | -$112K |
|
3139
Mitsubishi UFJ Financial
MUFG
$253B
| $876K | ﹤0.01% |
+161,345
| New | +$851K |
|
3140
ALPS Emerging Sector Dividend Dogs ETF
EDOG
$29.5M
| $875K | ﹤0.01% |
40,226
-15,949
| -28% | -$334K |
|
3141
Central Garden & Pet Co Class A
CENTA
$2.37B
| $874K | ﹤0.01% |
37,190
-11,145
| -23% | -$250K |
|
3142
Lindsay Corp
LNN
$1.13B
| $874K | ﹤0.01% |
9,104
+1,160
| +15% | +$106K |
|
3143
Usana Health Sciences
USNA
$408M
| $874K | ﹤0.01% |
11,134
-3,105
| -22% | -$229K |
|
3144
PUT
Linde
LIN
$221B
| $873K | ﹤0.01% |
4,100
-1,700
| -29% | -$343K |
|
|
BITA
3145
DELISTED
Bitauto Holdings Limited
BITA
| $868K | ﹤0.01% |
58,476
-45,810
| -44% | -$692K |
|
3146
PUT
Medifast
MED
$109M
| $866K | ﹤0.01% |
7,900
| – | – |
|
|
STML
3147
DELISTED
Stemline Therapeutics, Inc.
STML
| $864K | ﹤0.01% |
81,351
+49,403
| +155% | +$490K |
|
3148
Collegium Pharmaceutical
COLL
$1.15B
| $863K | ﹤0.01% |
41,901
+14,847
| +55% | +$247K |
|
3149
Ingles Markets
IMKTA
$1.71B
| $858K | ﹤0.01% |
18,045
-522
| -3% | -$22.2K |
|
|
BPFH
3150
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $856K | ﹤0.01% |
71,128
+3,356
| +5% | +$38.9K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.